Drug Margin
Pro preview
Previewing Reddenda Pro— these are sample numbers. Add your NPI to see your real RateScore.Reveal my numbers — 30 sec, no card

Renegotiate once, lift all sites: providers ranked by their biggest documented gaps against their local-peer median. Documented opportunity, never guaranteed.

Drug Margin

Part B buy-and-bill

Part B buy-and-bill economics. Medicare pays the ASP payment limit (ASP + 6%) per drug; the 2% sequester trims only the Medicare-paid share. Your margin is what you net minus your acquisition cost. Enter your cost to see your real spread. Nothing is stored, no PHI.

The buy-and-bill spread

CMS sets the allowed at ASP + 6%. After the 2% sequester on the Medicare-paid portion, the net add-on lands near ASP + 4.3% at standard 20% coinsurance. You keep the spread between that and what you actually pay to acquire the drug. Commercial payers may pay more.

Your margin
Selected drug
Loading the CMS pricing file…
$

Entered here only, never stored. No PHI.

Part B drugs · highest-allowed first
Loading the CMS ASP pricing file…

Source: CMS Average Sales Price payment-limit file · public, updated quarterly · per the HCPCS billing unit shown. Medicare-based; commercial payers negotiate separately. Modeled, never a guarantee.

Book a discovery call to map this across your actual billed J-code volume and your commercial contracts, identifying the drugs where your real spread is thinnest. See where to renegotiate first — every provider ranked by documented opportunity, rolled up to one payer×specialty lever. Book a call to roll up all your sites.

Schedule a call